Still no bioterror work at Texas A&M

Research on bioterrorist agents at Texas A&M University is linkurl:still suspended;http://www.the-scientist.com/blog/display/53600/ due to breaches in biosafety practices, although the university said last year it expected to be cleared to continue such work by the end of 2007. "The program continues to be on hold," Sherylon Carroll of the university's press office told The Scientist. "We are waiting for feedback from the Centers for Disease Control." The CDC suspended the university's bioterro

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Research on bioterrorist agents at Texas A&M University is linkurl:still suspended;http://www.the-scientist.com/blog/display/53600/ due to breaches in biosafety practices, although the university said last year it expected to be cleared to continue such work by the end of 2007. "The program continues to be on hold," Sherylon Carroll of the university's press office told The Scientist. "We are waiting for feedback from the Centers for Disease Control." The CDC suspended the university's bioterrorism research last year, after it emerged that a lab working with Brucella failed to report a worker's exposure to the pathogen. The finding led to a linkurl:flurry of revelations;http://www.the-scientist.com/blog/display/53673/ about biosafety lapses in academic labs around the country. The Dallas Morning News linkurl:reported;http://www.dallasnews.com/sharedcontent/dws/news/texassouthwest/stories/122707dntexa&mbiolabs.2d386e2.html last week that the agency has given Texas A&M no information about when the university might restart the research program. "They have given us absolutely no clue or sign as to when this thing will be resolved," the university's deputy chancellor, Jay Kimbrough, told the newspaper. A CDC representative told the newspaper that the investigation was still open, and did not give a timeframe for its resolution. Nor has the Health and Human Services Office of the Inspector General informed the university how much it would be fined for its biosafety problems. In September, a University of California lab was linkurl:fined $450,000;http://oig.hhs.gov/fraud/enforcement/administrative/cmp/cmpitems.html#6 for incorrectly shipping anthrax to another lab.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies